Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
0.767
-0.002 (-0.26%)
Oct 7, 2024, 4:00 PM EDT - Market closed
Quince Therapeutics Market Cap
Quince Therapeutics has a market cap or net worth of $33.19 million as of October 7, 2024. Its market cap has decreased by -22.08% in one year.
Market Cap
33.19M
Enterprise Value
-10.94M
1-Year Change
-22.08%
Ranking
Category
Stock Price
$0.77
Market Cap Chart
Since May 9, 2019, Quince Therapeutics's market cap has decreased from $855.60M to $33.19M, a decrease of -96.12%. That is a compound annual growth rate of -45.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 4, 2024 | 34.10M | -24.22% |
| Dec 29, 2023 | 45.00M | 95.65% |
| Dec 30, 2022 | 23.00M | -93.90% |
| Dec 31, 2021 | 377.10M | -53.98% |
| Dec 31, 2020 | 819.50M | -45.64% |
| Dec 31, 2019 | 1.51B | 76.19% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unicycive Therapeutics | 35.26M |
| Acurx Pharmaceuticals | 34.93M |
| Ocuphire Pharma | 34.58M |
| Xilio Therapeutics | 34.28M |
| BriaCell Therapeutics | 34.14M |
| Nortech Systems | 33.98M |
| DarioHealth | 33.93M |
| Vicarious Surgical | 33.67M |